Rankings
Pricing
Log In
Free Trial
JP-listed companies
Renascience Inc.
Renascience Inc.
JP:4889
Market cap
¥4.5B
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
JPY
xbrli:pure
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Mar 31,
2020
Mar 31,
2021
Mar 31,
2022
Mar 31,
2023
Mar 31,
2024
Profit (loss) before income taxes
-184
-100
-253
-334
-256
Depreciation
3
3
3
1
2
Impairment losses
-
-
11
-
5
Interest income
-0
-0
-0
-0
-0
Decrease (increase) in trade receivables
-
-
-
-
-4
Decrease (increase) in prepaid expenses
-0
-4
-24
2
-0
Decrease (increase) in accounts receivable - other
1
-
-
-
-0
Increase (decrease) in accounts payable - other
4
22
-6
68
26
Increase (decrease) in accrued expenses
-2
-1
0
-0
0
Decrease (increase) in other assets
-
-1
-1
1
0
Increase (decrease) in other liabilities
1
-3
13
-7
-0
Other, net
0
-6
-0
-15
0
Subtotal
-177
-73
-225
-283
-229
Interest received
0
0
0
0
0
Income taxes paid
-0
-0
-0
-1
-2
Net cash provided by (used in) operating activities
-178
-89
-230
-285
-231
Purchase of property, plant and equipment
-
-1
-1
-2
-2
Proceeds from refund of guarantee deposits
-
-
1
3
-
Other payments
-
-
-
-0
-
Other proceeds
-
-
-
-
0
Net cash provided by (used in) investing activities
-381
-2
-0
0
-2
Proceeds from long-term borrowings
380
96
104
110
47
Net cash provided by (used in) financing activities
380
136
1,592
110
47
Net increase (decrease) in cash and cash equivalents
-179
45
1,361
-174
-186